INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 3 filers reported holding INFINITY PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $421,000 | -45.9% | 80,000 | -19.2% | 0.14% | -66.7% |
| Q4 2015 | $778,000 | -58.2% | 99,000 | -55.1% | 0.42% | -51.8% |
| Q3 2015 | $1,863,000 | -51.5% | 220,618 | -37.1% | 0.87% | -29.6% |
| Q2 2015 | $3,841,000 | -43.1% | 350,604 | -27.5% | 1.24% | -23.7% |
| Q1 2015 | $6,754,000 | -2.4% | 483,262 | +18.0% | 1.63% | -10.5% |
| Q4 2014 | $6,922,000 | +57.7% | 409,715 | +25.4% | 1.82% | +16.4% |
| Q3 2014 | $4,388,000 | +187.2% | 326,821 | +172.4% | 1.56% | -11.5% |
| Q2 2014 | $1,528,000 | +7.1% | 120,000 | 0.0% | 1.77% | +29.1% |
| Q1 2014 | $1,427,000 | – | 120,000 | – | 1.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 7,866,108 | $25,408,000 | 4.32% |
| Nine Chapters Capital Management LLC | 91,500 | $296,000 | 0.40% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,969,225 | $6,361,000 | 0.24% |
| Orbimed Advisors | 3,250,300 | $10,498,000 | 0.12% |
| PINNACLE ASSOCIATES LTD | 1,306,679 | $4,221,000 | 0.08% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 810,232 | $2,617,000 | 0.07% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 270,417 | $873,000 | 0.06% |
| Rock Springs Capital Management LP | 270,000 | $872,000 | 0.05% |
| ALGERT GLOBAL LLC | 39,876 | $129,000 | 0.04% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 391,671 | $1,265,000 | 0.03% |